Here’s my latest video!
After going on Joe Rogan’s podcast, Paul Saladino, MD, posted his show notes, which included his blood test results. Based on that data, is his biological age optimal while on a carnivore diet?
Dr. Adam Freund PhD., Calico Life Sciences, Discussing Google Quest to Solve Aging.
Ira Pastor, ideaXme life sciences ambassador interviews Dr Adam Freund, PhD, Principal Investigator at Calico Life Sciences (Calico). https://www.calicolabs.com
Continue reading “Google / Alphabet’s Quest to Solve Aging” »
Can sub-zero stasis help humans escape death? In episode five of Hacking the Apocalypse, Claire Reilly goes inside a cryonics facility to investigate the experimental search for a second life.
CNET playlists: https://www.youtube.com/user/CNETTV/playlists
Download the new CNET app: https://cnet.app.link/GWuXq8ExzG
Like us on Facebook: https://www.facebook.com/cnet
Follow us on Twitter: https://www.twitter.com/cnet
Follow us on Instagram: http://bit.ly/2icCYYm
CJD happens when proteins called prions, which form incorrectly, find their way into the brain. Prions have the unfortunate, destructive ability to deform the proteins around them as well. As the prions gradually eat away at neurons, they create sponge-like holes in the brain. This leads to dementia, loss of bodily function, and eventually coma and death.
A new study — published last month in the journal Scientific Reports — looked at national data on people 50 years and older from Japan between the years 2005 and 2014 and found a gradual rise in the country’s CJD cases and deaths. The increase in both was most prominent among those older 70, but the Okayama University scientists behind the research saw a rise of CJD even after the data had been corrected for age.
“Given this trend in aging of population, the disease burden of CJD will continue to increase in severity,” the scientists wrote in their paper. “Our findings thus recommend that policymakers be aware of the importance of CJD and focus on preparing to address the increasing prevalence of dementia.”
A gene therapy that could restore the fading sight of the elderly is being tested on humans for the first time after positive results in blind mice.
It could be used to treat age-related macular degeneration, a common condition that usually first affects people in their 50s and 60s, scientists said.
It involves a one-time injection of a modified virus into the eye. This viral vector is altered to contain a synthetic gene that produces a protein that plays a critical role in the perception of light.
Though its a bit old, and sometimes innacurate or snarky in narration, it’s still the most detailed depiction of the cryonics process — the procedure itself on a real person, the person preserved before dying and her family as they decide to do this, deal with her death, and reflect on it after she’s preserved. It’s quite emotional and sometimes graphic, but well worth watching. Will it work? Maybe. But if you are NOT preserved there is NO chance at all. From your perspective it’d be like waking up right after dying in some distant future without feeling like any time passed at all.
That sounds a hell of a lot more appealing and likely than a bearded man on a fluffy cloud winking at me after I die.
Continue reading “Frozen humans brought back to life | 60 Minutes Australia” »
The researchers found that while equol production did not appear to impact levels of amyloid-beta deposited within the brain, it was associated with reduced white matter lesion volumes. Sekikawa’s team also discovered that high levels of isoflavones—soy nutrients that are metabolized into equol—had no effect on levels of white matter lesions or amyloid-beta when equol wasn’t produced.
According to Sekikawa, the ability to produce equol from soy isoflavones may be the key to unlocking protective health benefits from a soy-rich diet, and his team has previously shown that equol production is associated with a lower risk of heart disease. As heart disease is strongly associated with cognitive decline and dementia, equol production could help protect the aging brain as well as the heart.
A metabolite produced following consumption of dietary soy may decrease a key risk factor for dementia—with the help of the right bacteria, according to a new discovery led by researchers at the University of Pittsburgh Graduate School of Public Health.
Continue reading “Bacterial metabolism of dietary soy may lower risk factor for dementia” »
Have you gotten your genome sequenced yet? How important do you think genetic testing is to planning your own personalized longevity regimen?
We cover the benefits of genetic testing for longevity, and why you should consider getting a DNA test if you want to extend your lifespan.
OneSkin Technologies is a longevity company started by a team of incredible female PHDs and entrepreneurs, who have been using cutting edge technology to identify the senescent cells that cause your skin to age.
⠀⠀⠀
Discover how they use key peptide molecules to eliminate those senescent cells, making you look and feel 10 years younger.
Subscribe for Peter’s latest tech insights & updates: https://www.diamandis.com/subscribe
Our immune system’s capacity to mount a well-regulated defense against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65. At the same time, research has shown that immunotherapy targeting neurotoxic forms of the peptide amyloid beta (oligomeric Aβ) may halt the progression of Alzheimer’s disease, the most common age-related neurodegenerative disease.
A team led by Chuanhai Cao, Ph.D., of the University of South Florida Health (USF Health), has focused on overcoming, in those with impaired immunity, excess inflammation and other complications that interfere with development of a therapeutic Alzheimer’s vaccine.
Now, a preclinical study by Dr. Cao and colleagues indicates that an antigen-presenting dendritic vaccine with a specific antibody response to oligomeric Aβ may be safer and offer clinical benefit in treating Alzheimer’s disease. The vaccine, called E22W42 DC, uses immune cells known as dendritic cells (DC) loaded with a modified Aβ peptide as the antigen.
